StockTipsArenaBeta

BUY Anthem Biosciences Limited — Vishvesh Chauhan, ChaseAlpha

BUYAnthem Biosciences Limited
Anthem Biosciences share price target & all analyst calls

byVishvesh Chauhan, ChaseAlphaHorizon: 1 year6 Nov 2026via Zee Business (Live)

Entry₹916.5Inferred
Target₹1,100
Total upside +20.02%
Stop loss₹775-15.44% risk
CMP₹915.551d ago
Active-0.10%+20.15%upside left 12 mo left
Follow Vishvesh Chauhan for new callsGet alertsWatch ANTHEM for new buy/sell callsGet alertsSee 4 other Long-term calls on ANTHEMSee 541 other Long-term picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

As of 7 Nov, 5:28 pm IST
4 supporting5 neutral1 opposing
Supports the BUY call (4)

Long-term trend bullish — 200-day average rising over the past quarter

Technicals · trend·6 Nov · yesterday

Anthem Biosciences reported Q2 FY27 consolidated revenue of ₹5,940 million, EBITDA of ₹3,304 million, and PAT of ₹2,115 million, showing year-on-year growth in profitability and margins.

BSE · Company Update·3 Nov · 3d ago

(opens in new tab)

4 other SEBI-registered advisors have active long-term BUY calls on this stock

Advisor consensus · same horizon·19 Oct · 3w ago

Neutral / worth noting (5)

The company reported its unaudited standalone and consolidated financial results for the quarter and half year ended September 30, 2026.

BSE · Board Meeting·3 Nov · 3d ago

(opens in new tab)
Weighs against the BUY call (1)

Anthem Biosciences block deal: Portsmouth Technologies sells 30 lakh shares worth Rs 250 crore

NewsEt-Markets·9 Oct · 4w ago

(opens in new tab)

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Anthem Biosciences

All analyst calls on Anthem Biosciences

More from Vishvesh Chauhan, ChaseAlpha

Every call and its outcome